Business Description
Sutro Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : US8693671021
Description
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 11.17 | |||||
| Equity-to-Asset | 0.32 | |||||
| Debt-to-Equity | 0.23 | |||||
| Debt-to-EBITDA | -0.58 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -0.42 | |||||
| Beneish M-Score | -0.04 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 24.9 | |||||
| 3-Year EBITDA Growth Rate | -9.8 | |||||
| 3-Year EPS without NRI Growth Rate | 0.2 | |||||
| 3-Year FCF Growth Rate | 5.7 | |||||
| 3-Year Book Growth Rate | -30.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -12.88 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.29 | |||||
| 9-Day RSI | 35.64 | |||||
| 14-Day RSI | 39.99 | |||||
| 6-1 Month Momentum % | 15.93 | |||||
| 12-1 Month Momentum % | -28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | |||||
| Quick Ratio | 4.5 | |||||
| Cash Ratio | 4.01 | |||||
| Days Sales Outstanding | 37.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 0.69 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -58.07 | |||||
| Net Margin % | -69.47 | |||||
| FCF Margin % | -75.41 | |||||
| ROE % | -65.18 | |||||
| ROA % | -25.04 | |||||
| ROIC % | -106.11 | |||||
| ROC (Joel Greenblatt) % | -134.68 | |||||
| ROCE % | -18.3 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.45 | |||||
| PB Ratio | 1.42 | |||||
| Price-to-Tangible-Book | 1.42 | |||||
| EV-to-EBIT | 0.86 | |||||
| EV-to-EBITDA | 0.96 | |||||
| EV-to-Revenue | -0.36 | |||||
| EV-to-Forward-Revenue | 0.05 | |||||
| EV-to-FCF | 0.48 | |||||
| Price-to-Net-Current-Asset-Value | 2.1 | |||||
| Price-to-Net-Cash | 3.9 | |||||
| Earnings Yield (Greenblatt) % | 116.28 | |||||
| FCF Yield % | -43.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:STRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sutro Biopharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 153.731 | ||
| EPS (TTM) ($) | -1.78 | ||
| Beta | 1.33 | ||
| Volatility % | 78.98 | ||
| 14-Day RSI | 39.99 | ||
| 14-Day ATR ($) | 0.373087 | ||
| 20-Day SMA ($) | 4.44225 | ||
| 12-1 Month Momentum % | -28 | ||
| 52-Week Range ($) | 2.005 - 6.13 | ||
| Shares Outstanding (Mil) | 76.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sutro Biopharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sutro Biopharma Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sutro Biopharma Inc Frequently Asked Questions
What is Sutro Biopharma Inc(STRO)'s stock price today?
The current price of STRO is $3.47. The 52 week high of STRO is $6.13 and 52 week low is $2.01.
When is next earnings date of Sutro Biopharma Inc(STRO)?
The next earnings date of Sutro Biopharma Inc(STRO) is 2024-05-15 Est..
Does Sutro Biopharma Inc(STRO) pay dividends? If so, how much?
Sutro Biopharma Inc(STRO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers